Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
171. |
ECCT/25/03/01 | MK-5684_MSD (mCRPC) A Phase 3, Randomized, Open-label Study of MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed On or After Prior Treatment with One Next-generation Hormonal Agent (NHA) |
Principal Investigator(s) 1. PROF MANSOOR NOORALI SALEH Site(s) in Kenya AGA KHAN UNIVERSITY HOSPITAL NAIROBI |
20-05-2025 |
View |
172. |
ECCT/15/08/01 | Rifapentine During Intensive Phase TB Treatment Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: a randomized, open-label, controlled, phase 3 clinical trial |
Principal Investigator(s) 1. Elisha Ochieng Okeyo Site(s) in Kenya KEMRICDC, KISUMU, KENYA |
05-05-2016 |
View |
173. |
ECCT/13/04/09 | Short-course RPT/INH for latent TB in HIV-infected individuals Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection |
Principal Investigator(s) 1. Deborah C. Langat Site(s) in Kenya 1. Kenya Medical Research Institute Walter Reed Project Clinical Research Centre (Kericho county) 2. Moi University Clinical Research Centre (Uasin Gishu county) |
26-03-2013 |
View |
174. |
ECCT/26/06/03 | C1091009 - Study Site 1254 Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants |
Principal Investigator(s) 1. Fredrick Kipyego Sawe Site(s) in Kenya 1. Kenya Medical Research Institute Walter Reed Project (Kericho county) 2. KEMRI Butere Clinical Research Centre (Kakamega county) 3. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county) 4. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county) |
08-11-2026 |
View |
175. |
ECCT/24/06/04 | ALNASA A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
Principal Investigator(s) 1. Jacqueline Mirera Site(s) in Kenya 1. Clinical Research Health Network (CREA-N) (Machakos county) |
23-10-2024 |
View |
176. |
ECCT/08/08/02 | Parallel Comparison of Tenofovir and Emtricitabine/tenofovir Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition within HIV-1 Discordant Couples |
Principal Investigator(s) 1. Edwin Onyango Were Site(s) in Kenya 1. Eldoret Site (Uasin Gishu county) 2. Kisumu Site (Kisumu county) 3. Thika Site (Kiambu county) 4. Nairobi Site (Nairobi City county) |
25-07-2008 |
View |
177. |
ECCT/25/08/01 | MK-8527 as HIV-1 PrEP in Women A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis in Women |
Principal Investigator(s) 1. Maricianah Onono Site(s) in Kenya 1. KEMRI-RCTP KISUMU (Kisumu county) 2. Kargeno Research and Policy Hub KEMRI-CMR KISUMU (Kisumu county) 3. KEMRI-PHRD, Thika (Kiambu county) 4. UW KNH - Rachuonyo County Hospital (Homa Bay county) |
21-11-2025 |
View |
178. |
ECCT/26/03/03 | LIBRA A 52-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group, group sequential, Phase 3 study to evaluate the efficacy and safety of rilzabrutinib in patients aged 10 to 65 years with sickle-cell disease (LIBRA) |
Principal Investigator(s) 1. Jessie Githanga Site(s) in Kenya Getrudes’s Children\'s Hospital |
23-10-2026 |
View |
179. |
ECCT/21/06/08 | VAT00008 A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older |
Principal Investigator(s) 1. Saleh Mansoor Site(s) in Kenya 1. Aga Kahn University Nairobi (Nairobi City county) 2. Kenya Medical Research Institute (Kisumu county) 3. KEMRI/Walter Reed Project Research Center (Kericho county) 4. Ganjoni Clinic (Mombasa county) 5. KEMRI/CCR Partners in Health R&D (PHRD (Kiambu county) 6. KEMRI/CCR Partners in Health R&D (PHRD (Kiambu county) 7. Kenya Medical Research Institute (Nairobi City county) 8. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county) 9. Moi University Clinical Research Centre (Uasin Gishu county) 10. KEMRI CCR-Butere County Hospital Site (Kakamega county) |
16-08-2021 |
View |
180. |
ECCT/16/06/02 | A5263: A Randomized Comparison of Three Regimens of Chemotherapy with Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings A Randomized Comparison of Three Regimens of Chemotherapy with Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings |
Principal Investigator(s) 1. Vincent Oliver Otieno Site(s) in Kenya 1. Kisumu CRS (Kisumu county) |
28-07-2016 |
View |